Concepedia

Robert W. Ross

RW

Statistics

Publications

44

Citations

16K

H-Index

32

Active since

1947

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Memorial Sloan Kettering Cancer Center

Beth Israel Deaconess Medical Center

Robert W. Ross is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and urology.

Top concepts

Publications per year

1947–2020

44

Publications

44

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 10.9K citations · Full text

Gene Therapy in a Patient with Sickle Cell Disease

Jean‐Antoine Ribeil, Salima Hacein‐Bey‐Abina, Emmanuel Payen et al. · New England Journal of Medicine · 2017 · 658 citations · Full text

, , +15

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Alexis A. Thompson, Mark C. Walters, Janet L. Kwiatkowski et al. · New England Journal of Medicine · 2018 · 646 citations · Full text

Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

Toni K. Choueiri, Ulka N. Vaishampayan, Jonathan E. Rosenberg et al. · Journal of Clinical Oncology · 2012 · 455 citations · Full text

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Lecia V. Sequist, Scott Gettinger, Neil Senzer et al. · Journal of Clinical Oncology · 2010 · 330 citations · Full text

1–5 of 44